BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23192922)

  • 1. Opsoclonus myoclonus syndrome associated with GQ1b antibodies.
    Morales-Briceño H; Rodríguez-Violante M; Cervantes-Arriaga A; Irani SR; Lees AJ; Silveira-Moriyama L
    Mov Disord; 2012 Nov; 27(13):1615-6. PubMed ID: 23192922
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary for "Opsoclonus myoclonus syndrome associated with GQ1b antibodies".
    Espay AJ
    Mov Disord; 2012 Nov; 27(13):1616-7. PubMed ID: 23192923
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab and intravenous immunoglobulins for relapsing postinfectious opsoclonus-myoclonus syndrome.
    Leen WG; Weemaes CM; Verbeek MM; Willemsen MA; Rotteveel JJ
    Pediatr Neurol; 2008 Sep; 39(3):213-7. PubMed ID: 18725071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsoclonus-myoclonus syndrome and limbic encephalitis associated with GABAB receptor antibodies in CSF.
    DeFelipe-Mimbrera A; Masjuan J; Corral Í; Villar LM; Graus F; García-Barragán N
    J Neuroimmunol; 2014 Jul; 272(1-2):91-3. PubMed ID: 24814391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False positive autoantibodies to glutamic acid decarboxylase in opsoclonus-myoclonus-ataxia syndrome after intravenous treatment with immunoglobulin.
    de Beer F; Schreurs MW; Foncke EM
    Clin Neurol Neurosurg; 2009 Sep; 111(7):643-4. PubMed ID: 19442432
    [No Abstract]   [Full Text] [Related]  

  • 6. Adult-onset opsoclonus-myoclonus syndrome due to West Nile Virus treated with intravenous immunoglobulin.
    Hébert J; Armstrong D; Daneman N; Jain JD; Perry J
    J Neurovirol; 2017 Feb; 23(1):158-159. PubMed ID: 27473195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Opsoclonus-myoclonus syndrome associated with Mycoplasma pneumoniae infection].
    Chemli J; Ketata S; Dalhoumi A; Ajmi H; Hassayoun S; Fodha I; Boujaafar N; Harbi A
    Arch Pediatr; 2007 Aug; 14(8):1003-6. PubMed ID: 17543509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic opsoclonus and cerebellar ataxia related to anti-Ma2 antibody: a case report.
    Mélé N; Hautefort C; Toledano A; Delattre JY; Psimaras D
    J Neurol; 2016 Feb; 263(2):405-406. PubMed ID: 26754007
    [No Abstract]   [Full Text] [Related]  

  • 9. Opsoclonus-myoclonus syndrome associated with benign ovarian teratoma.
    Fitzpatrick AS; Gray OM; McConville J; McDonnell GV
    Neurology; 2008 Apr; 70(15):1292-3. PubMed ID: 18391162
    [No Abstract]   [Full Text] [Related]  

  • 10. Presentation of opsoclonus myoclonus ataxia syndrome with glutamic acid decarboxylase antibodies.
    Bhandari HS
    BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22878989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opsoclonus-myoclonus syndrome in anti-N-methyl-D-aspartate receptor encephalitis.
    Kurian M; Lalive PH; Dalmau JO; Horvath J
    Arch Neurol; 2010 Jan; 67(1):118-21. PubMed ID: 20065141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsoclonus myoclonus syndrome in a patient with Japanese encephalitis: a case report.
    Sountharalingam S; Herath HMMTB; Wijegunasinghe D; Senanayke S
    J Med Case Rep; 2017 Oct; 11(1):294. PubMed ID: 29058581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
    Burke MJ; Cohn SL
    Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to rituximab in 3 children with opsoclonus-myoclonus syndrome resistant to conventional treatments.
    Battaglia T; De Grandis E; Mirabelli-Badenier M; Boeri L; Morcaldi G; Barabino P; Intra C; Naselli F; Pistoia V; Veneselli E; Conte M
    Eur J Paediatr Neurol; 2012 Mar; 16(2):192-5. PubMed ID: 21737325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of adult-onset poststreptococcal opsoclonus-myoclonus syndrome.
    Radic B; Cajic I; Petelin Gadze Z; Sulentic V; Nankovic S
    Acta Neurol Belg; 2018 Dec; 118(4):541-542. PubMed ID: 29713906
    [No Abstract]   [Full Text] [Related]  

  • 16. Opsoclonus-Myoclonus Syndrome: A New Era of Improved Prognosis?
    Galstyan A; Wilbur C; Selby K; Hukin J
    Pediatr Neurol; 2017 Jul; 72():65-69. PubMed ID: 28479124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus.
    Bell J; Moran C; Blatt J
    Pediatr Blood Cancer; 2008 Feb; 50(2):370-1. PubMed ID: 16652344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Paraneoplastic opsoclonus-myoclonus syndrome--a review].
    Matsumoto H; Ugawa Y
    Brain Nerve; 2010 Apr; 62(4):365-9. PubMed ID: 20420176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus.
    Pranzatelli MR; Slev PR; Tate ED; Travelstead AL; Colliver JA; Joseph SA
    Pediatr Neurol; 2011 Jul; 45(1):27-33. PubMed ID: 21723456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult-onset Opsoclonus-Myoclonus Syndrome Associated With Ganglionic Acetylcholine Receptor Autoantibody.
    Galli JR; Clardy SL; Paz Soldán MM
    Neurologist; 2016 Nov; 21(6):99-100. PubMed ID: 27801769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.